Phytotech Medical Limited (ASX:PYL), the Australian owned Medical Grade Cannabis (MGC) company and the first MGC company to list on the Australian Stock Exchange, is pleased to provide an update on the research and development of its MGC based therapeutic delivery systems for administering Medical Grade Cannabis (MGC).
PhytoTech Medical Limited (ASX:PYL), the Australian owned Medical Grade Cannabis (MGC) company and the first MGC company to list on the Australian Stock Exchange, today announces that the research and development into its delivery systems for administering Medical Grade Cannabis (MGC) based therapeutic products has now commenced.
PhytoTech Medical Limited (ASX:PYL), wishes to advise that Ross Smith has resigned as a director effective immediately.
PhytoTech Medical Limited (ASX:PYL), the Australian owned Medical Grade Cannabis (MGC) company and the first MGC company to list on the Australian Stock Exchange, wishes to advise that Miss Erlyn Dale has been appointed company secretary of the Company, effective from 1 February 2015.
PhytoTech Medical Limited (ASX:PYL), the Australian owned Medical Cannabis (MC) company and the first MC company to list on the ASX, is pleased to announce the appointment of Dr Daphna Heffetz, as CEO for the wholly owned subsidiary company in Israel.
Phytotech Medical Limited (ASX:PYL), the Australian owned Medical Cannabis (MC) company and the first MC company to list on the ASX, is pleased to announce the appointment of Dr. Benad Goldwasser as a Non-Executive Director to its Board of Directors.
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that it has signed an exclusive licensing and collaboration agreement with PhytoTech Medical Ltd. (ASX:PYL) for the development, manufacturing and marketing of a novel delivery system to enhance the bioavailability of cannabidiol (CBD) and/or THC, the active ingredients in cannabis, for the treatment of a variety of medical indications.
